AI assistant
Sending…
bioAffinity Technologies, Inc. — Director's Dealing 2023
May 11, 2023
35439_dirs_2023-05-11_1b925ac1-6ca3-48b1-93e3-31b4ba4d84f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2023-05-01
Reporting Person: Dougherty Michael Philip (Chief Financial Officer)
More from bioAffinity Technologies, Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 12
Earnings Release
2026
May 8
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 7
Investor Presentation
2026
Mar 26